Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

Companies

Displaying 1..10 of 13 - per page Next page
Order by
Drug Discovery, Drug Delivery Systems and Medical Devices Research More
Polyphor is a Swiss biotech company providing innovative, high quality products and services to big pharma and biotech customers. More
proLEMA AG is a private and independent consultancy company specialised in the life sciences and healthcare businesses. More
Debio finances and manages drug development for serious medical conditions More
Anbics is a biopharmaceutical company engaged in manufacture of bulk cephalosporin intermediates and in R&D of novel anti-infective treatment strategies for life-threatening infections More
A drug development and discovery company that focuses on metabolic, neuromuscular and niche CNS disorders. More
We specialise in the development & application of mammalian cell culture systems for the production of biologicals in minimal culture media. More
Drug Discovery More
Promote and facilitate the transfer of University-developed technology for society's use More
Displaying 1..10 of 13 - per page Next page
Order by
Partnering consultation free of charge
Bioiberica
Profile your company today
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us